Announced Fri, 30 Jan · 20:31 IST

Solara Active Pharma Sciences Limited has informed the Exchange about the Schedule of Investors/Analysts call to be held on Friday, February 06, 2026 to discuss the Company's unaudited financial results for the quarter ended December 31, 2025

Board & Shareholder Meetings View source PDF

SOLARA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Solara Active Pharma Sciences has informed the exchanges that it will host an investors and analysts call on Friday, February 06, 2026. The agenda of the call is to discuss the company's unaudited financial results for the quarter ended December 31, 2025 (Q3 FY26). No financial numbers, guidance, or management commentary have been shared in this filing — it is purely a notice informing the market about the upcoming call. Investors should watch for the company's earnings release and the management commentary during the call for actual performance details.

Likely market impact

This is a routine procedural disclosure and is unlikely to move the stock on its own. The real market reaction will depend on the actual Q3 FY26 numbers and outlook shared during the call on February 06, 2026.